
|Videos|July 8, 2011
Dr. Lichter on ASCO's Global Collaboration Focus
Author(s)Allen S. Lichter, MD
Dr. Allen S. Lichter Chief Executive Officer (CEO) of the American Society of Clinical Oncology on ASCO's Global Collaboration Focus
Advertisement
Allen S. Lichter, MD, the chief executive officer of the American Society of Clinical Oncology (ASCO) feels that in many respects ASCO is the world's oncology society. He explains the founders of the society recognized that cancer is a global problem and the exchange of ideas should be carried out globally. Fifty percent of the papers published in their journal come from overseas, over 50% of attendees at the 2011 annual meeting in Chicago were international, and the organization contains members come from 100 countries around the world.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5


































